ARNA Panacea Genomics is an Innovative Biotechnological Company

ARNA Panacea Genomics innovative biotechnology firm, was launched by a team of like-minded scientists and entrepreneurs and grew out of scientific and laboratory research into full-scale businesses. ARNA develop revolutionary early cancer detection methods specific to launch a line of diagnostic tests for the early detection of cancer in the global market
ARNA Panacea is a solution that provides to all participants who are interested in the market diagnosis of cancer in a new way to access and interact with the system to collect and store data for medical research. By using the token ARNA, the holder will be able to access their service and medical research data storage systems for use in professional medical purpose, and to raise funds to start new research.

Our mission: to increase life expectancy and reduce human death. ARNA relentlessly pursues this goal through sophisticated screening methods, correction of diagnosis, treatment, monitoring and improving patient compliance.

Our innovation: ARNA Genomics have discovered a technology that allows the development of very specific tests for cancer are different. In addition, the company also has developed a unique concept of platform-based ecosystem blockchain-class that is intended to be used as a tool to support the implementation of biotechnologies and R&D around the world.

Pledge: ARNA Genomics has completed its first product for the R&D-test ARNA breast cancer. Test colon cancer was in stage R&D. ARNA devoting all of our resources to complete the development of ARNA Elixir-a platform blockchain, which will hope will change the world by making the launch of the new biotech and cancer-fighting treatment solution is much easier, more cheaper and faster

The development panacea ARNA
ARNA Genomics will provide the entire market participants working with cancer a fundamental new way to access and interact with the data collection and storage of clinical trial environment. Using token ARNA holders would be able to pay for service members on other systems (e.g. cancer check-ups, tests, etc.), get access to the data storage system for medical experimentation for the use of medical professionals, pay for service users other systems or start fundraising for a new study.

In collaboration with FDA regulators (u.s. Food and Drug Administration), genomics ARNA will test Data storage systems fit to collect the evidential basis for use by the regulators for more product licensing opportunities (detection breast cancer ARNA BC) to the mass market US. ARNA Genomics will use existing methodologies and “best practices” are available for the successful development and implementation of these solutions to all members of the ecosystem ARNA Panacea:

Discuss and discover: the first phase of the project will include a discussion and evaluation of the major market players in terms of adaptation of the technology of Blockchain, as well as all technical requirements.
Design prototype: this phase & relates to the development of the prototype node Blockchain with a trusted partner to evaluate and perform comprehensive tests tions ARNA panacea.
Development: development of the model base system will be completed during this phase.
Usage: this stage involves the use of the elixir ecosystem as well as the involvement of ARNA new partners and market participants.
Application Support: ARNA Genomics will continue to support the system and its members for a limited period.

The concept of ARNA Panacea is a solution that provides to all participants who are interested in the market diagnosis of cancer in a new way to access and interact with the system to collect and store data for medical research. By using the token ARNA, the holder will be able to access their service and medical research data storage systems for use in professional medical purpose, and to raise funds to start new research

OUR TEAM

Egor Melnikov – Founder & CEO
George Nikitin – COO & co-founder
Anatoliy Melnikov – Scientific supervisor and creator of the ARNA BC test
Ilya Senechkin – PhD, Wageningen University, Netherlands
Sergey Chernyshev – Ph.D., molecular biotechnologist
Magomed Chatuev – Software architect and developer
Sergey Dolgachev – Entrepreneur and co-owner

DETAIL INFROMATION : 
Website : https://token.arnagenomics.com
Whitepaper : https://token.arnagenomics.com/ARNA_whitepaper_en.pdf
Facebook : https://www.facebook.com/arnagenomics
Twitter : https://twitter.com/ArnaGenomics
Telegram : https://t.me/arnagenomics
Medium : https://medium.com/@arnagenomics
Linkedin : https://www.linkedin.com/company/18169716/

My Profile:
https://bitcointalk.org/index.php?action=profile;u=1183913
My Ethereum Address:
0xD25856D7408b6b4C6918165424ac9A5B75Ac26fE